The 'Stop Chinese Fentanyl Act of 2025' directly targets Chinese entities involved in opioid and precursor production, expanding sanctions under the Fentanyl Sanctions Act. This bill creates immediate compliance burdens and financial risks for U.S. companies with chemical supply chain ties to China, impacting chemical manufacturers, pharmaceutical ingredient suppliers, and international logistics firms.
TICKER INTELLIGENCE
$SHW
Company & Legislative Profile
$SHW is a publicly traded company in the Chemicals sector. This company operates across Chemicals and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $SHW, including 1 bill. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
$SHW is currently facing 1 active congressional signal tracked by HillSignal. With 0 bullish, and 1 bearish signal, the average legislative impact score is 5.0/10. Key sectors affected include Chemicals, Pharmaceuticals and Logistics. Recent major catalysts include Stop Chinese Fentanyl Act of 2025. Below is the complete tracker of government activity affecting $SHW’s market performance.
1
Total Signals
5.0/10
Avg Impact
0
Bullish Signals
1
Bearish Signals
Related Sectors
Recent Congressional Signals for $SHW
Understanding These Signals
Get Full Access to $SHW Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Become a Member →